Postmenopausal Metastatic Breast Cancer: A Review of First-Line Treatment Options

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.2, Iss.2, 2003-01, pp. : 95-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer

By Riemsma Rob

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 9-24

Springer Publishing Company

Access to resources Recommend Favorite

First-Line Treatment of Metastatic Breast Cancer: Available Evidence and Current Recommendations

By Puglisi Fabio

American Journal of Cancer, Vol. 5, Iss. 2, 2006-01 ,pp. : 99-110

Adis International

Access to resources Recommend Favorite

Gemcitabine: In Combination with Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer

By Moen Marit D. Wellington Keri

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 327-333

Adis International

Access to resources Recommend Favorite

Influence of Droloxifene on Metastatic Breast Cancer as First-Line Endocrine Treatment

By Haarstad Helge Lønning Per E. Gundersen Stein Wist Erik Raabe Nils Kvinnsland Stener

Acta Oncologica, Vol. 37, Iss. 4, 1998-10 ,pp. : 365-368

Informa Healthcare

Access to resources Recommend Favorite

Gemcitabine in Combination with Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer: A Viewpoint by Denise A. Yardley

By Yardley Denise A.

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 334-335

Adis International

Access to resources Recommend Favorite